PPARG and metabolic dysfunction-associated steatotic liver disease: Studies in the liver of obese NAFLD patients revealed significant upregulation of PPAR-γ mRNA levels over those in lean control subjects [94], in agreement with data assessing the PPAR-γ2 isoform [100].